272 Capital LP Boosts Position in Definitive Healthcare Corp. (NASDAQ:DH)

272 Capital LP boosted its holdings in shares of Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 74.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,114,080 shares of the company's stock after buying an additional 476,766 shares during the period. Definitive Healthcare makes up 2.6% of 272 Capital LP's holdings, making the stock its 12th largest position. 272 Capital LP owned approximately 0.96% of Definitive Healthcare worth $4,980,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Point72 DIFC Ltd raised its stake in Definitive Healthcare by 759.9% in the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company's stock worth $42,000 after acquiring an additional 8,215 shares during the last quarter. Intech Investment Management LLC purchased a new position in shares of Definitive Healthcare in the third quarter worth about $55,000. Bleakley Financial Group LLC purchased a new stake in Definitive Healthcare in the third quarter valued at approximately $74,000. Glenmede Trust Co. NA boosted its position in Definitive Healthcare by 41.1% in the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company's stock valued at $82,000 after buying an additional 5,362 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new position in Definitive Healthcare in the 3rd quarter worth approximately $84,000. 98.67% of the stock is currently owned by hedge funds and other institutional investors.

Definitive Healthcare Stock Down 0.2 %

Shares of NASDAQ:DH traded down $0.01 during trading hours on Friday, reaching $4.49. The stock had a trading volume of 210,901 shares, compared to its average volume of 721,441. Definitive Healthcare Corp. has a 1 year low of $3.19 and a 1 year high of $10.62. The firm's 50 day moving average is $4.41 and its 200-day moving average is $4.72. The stock has a market capitalization of $518.68 million, a price-to-earnings ratio of -1.45, a P/E/G ratio of 3.29 and a beta of 1.40. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on DH shares. BTIG Research initiated coverage on shares of Definitive Healthcare in a research note on Tuesday, September 17th. They issued a "buy" rating and a $7.00 target price for the company. Needham & Company LLC reissued a "hold" rating on shares of Definitive Healthcare in a research note on Friday, November 8th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $5.81.

Insider Activity at Definitive Healthcare

In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of the stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the transaction, the insider now owns 433,830 shares in the company, valued at approximately $2,039,001. This represents a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 14.84% of the company's stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.